Article
Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity.
Clinical pharmacology and therapeutics - 1 Mar 2025
Maillard Maud, Nguyen Jenny Q, Yang Wenjian, Hoshitsuki Keito, Relling Mary V, Caudle Kelly E, Crews Kristine R, Jeha Sima, Inaba Hiroto, Pui Ching-Hon, Bhatia Smita, Karol Seth E, Antillon-Klussmann Federico G, Haidar Cyrine E, Bhojwani Deepa, Yang Jun J
Abstract excerpt
Nudix hydrolase 15 (NUDT15) deficiency is strongly associated with thiopurine-induced myelosuppression. Currently, testing for NUDT15 deficiency is based on the genotyping of the most frequent and clinically characterized no-function variants, that is, *2, *3 and *9. The Hispanic/Latino-predominant variant NUDT15 *4 (p.R139H) is classified as "uncertain function" by the Clinical Pharmacogenetics Implementation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
